Our Parent Company, RespireRx Pharmaceuticals Inc., Announces a Department of Defense Award to Fund a Phase 2 Clinical Study to Improve Bladder Function in Patients with Spinal Cord Injury
RespireRx Pharmaceuticals Inc. Announces a Department of Defense Award to Fund a Phase 2 Clinical Study to Determine the Safety and...